-

Yi Pu1,2, Guanyu Zhou2,3, Kejia Zhao2,3,4

  • 1Laboratory of Mitochondria and Metabolism, Department of Burn and Reconstructive Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Cancers
|July 14, 2023
PubMed
概括

复发性质瘤,通常对标准治疗有抗性,在免疫治疗中显示出有前途. 将免疫检查点封锁与其他策略 (如抗血管生成抗体) 结合起来,可以增强抗瘤反应.